To study metastatic pancreatic cancer in vivo, KC mice have been crossed with loss-of-function tumor suppressor lines, such as mutant p53 (KPC) [24] and p16-Ink4a/p19-Arf (KIC or KPP) [20]. This evidence concerns the gene CDKN2A and neoplasm.